Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5448849 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRPIK3CDTP53CYP1A2 | |
| SCHEMBL5448855 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRPIK3CDTP53CYP1A2 | |
| SCHEMBL19369915 | 0.79 | PIK3CD (0.31) | PIK3CD | |
| SCHEMBL2190101 | 0.77 | PIK3CD (0.30) | PIK3CD | |
| SCHEMBL22648547 | 0.77 | TAS1R3 (0.31) | ALDH1A1TSHRCYP2D6 | |
| SCHEMBL23033819 | 0.75 | DGAT1 (0.43) | — | |
| SCHEMBL9159698 | 0.75 | ALDH1A1 (0.33) | ALDH1A1TSHRPIK3CD | |
| SCHEMBL13504616 | 0.72 | MEN1 (0.34) | ALDH1A1TSHRPIK3CDCYP2D6 | |
| SCHEMBL19578354 | 0.72 | CA12 (0.33) | ALDH1A1TSHRPIK3CD | |
| SCHEMBL12175227 | 0.72 | CA12 (0.33) | ALDH1A1TSHRPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188085-B2 | Antifungal agents | MERCK SHARP & DOHME CORP. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20110224228-A1 | ANTIFUNGAL AGENTS | MERCK SHARP & DOHME CORP. (US) | 2011-09-15 | — | — | US | disclosed |
| US-20100113439-A1 | Antifungal agents | MERCK & CO., INC. (US) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224228-A1 | ANTIFUNGAL AGENTS | GMDS, GBA3, UGGT1 | ALDH1A1 720/4885TSHR 4783/4885PIK3CD 1243/4885 |
| US-20100113439-A1 | Antifungal agents | GMDS, GBA3, UGGT1 | ALDH1A1 678/4885TSHR 4815/4885PIK3CD 1430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.